FGFR3-autoantibodies are not simple biomarkers.
We demonstrate a mechanism via extraceullar binding of autoantibodies to FGFR3 and how to block it.
We think targeting FGFR3 autoantibodies is a new therapeutic entry point for autoimmune neuropathies.
#Therapeutics #AutoimmunePain
0
0
1
0
